Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Monoclonal Antibodies Market 2018, Forecast to 2023
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
Scope of the Report:
This report focuses on the Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The worldwide market for Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Monoclonal Antibodies, with sales, revenue, and price of Monoclonal Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The worldwide market for Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- AbbVie
- Roche
- Johnson & Johnson
- Amgen
- Merck
- BMS
- Eli Lilly
- Formation Biologics
- Genmab
- GlaxoSmithKline
- Human Genome Sciences
- mmunogen
- MedImmune
- Novartis
- Pfizer
- Seattle Genetics
- Stemcentrx
- Synthon Biopharmaceuticals
- Takeda
- Teva
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Cancer
- Autoimmune Diseases
- Infection
- Hematological Diseases
- Others
- Oncology
- Autoimmune and inflammatory diseases
- Respiratory diseases
- Ophthalmology
Chapter 1, to describe Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Monoclonal Antibodies, with sales, revenue, and price of Monoclonal Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Cancer
1.2.2 Autoimmune Diseases
1.2.3 Infection
1.2.4 Hematological Diseases
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Autoimmune and inflammatory diseases
1.3.3 Respiratory diseases
1.3.4 Ophthalmology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.1.1 AbbVie Description
2.1.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.1.2 AbbVie Monoclonal Antibodies Product Introduction
2.1.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.1.2.2 Monoclonal Antibodies Product Information
2.1.3 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global AbbVie Monoclonal Antibodies Market Share in 2017
2.2 Roche
2.2.1 Business Overview
2.2.1.1 Roche Description
2.2.1.2 Roche Headquarter, Main Business and Finance Overview
2.2.2 Roche Monoclonal Antibodies Product Introduction
2.2.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.2.2.2 Monoclonal Antibodies Product Information
2.2.3 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Roche Monoclonal Antibodies Market Share in 2017
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.1.1 Johnson & Johnson Description
2.3.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.3.2 Johnson & Johnson Monoclonal Antibodies Product Introduction
2.3.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.3.2.2 Monoclonal Antibodies Product Information
2.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Johnson & Johnson Monoclonal Antibodies Market Share in 2017
2.4 Amgen
2.4.1 Business Overview
2.4.1.1 Amgen Description
2.4.1.2 Amgen Headquarter, Main Business and Finance Overview
2.4.2 Amgen Monoclonal Antibodies Product Introduction
2.4.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.4.2.2 Monoclonal Antibodies Product Information
2.4.3 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Amgen Monoclonal Antibodies Market Share in 2017
2.5 Merck
2.5.1 Business Overview
2.5.1.1 Merck Description
2.5.1.2 Merck Headquarter, Main Business and Finance Overview
2.5.2 Merck Monoclonal Antibodies Product Introduction
2.5.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.5.2.2 Monoclonal Antibodies Product Information
2.5.3 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Merck Monoclonal Antibodies Market Share in 2017
2.6 BMS
2.6.1 Business Overview
2.6.1.1 BMS Description
2.6.1.2 BMS Headquarter, Main Business and Finance Overview
2.6.2 BMS Monoclonal Antibodies Product Introduction
2.6.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.6.2.2 Monoclonal Antibodies Product Information
2.6.3 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global BMS Monoclonal Antibodies Market Share in 2017
2.7 Eli Lilly
2.7.1 Business Overview
2.7.1.1 Eli Lilly Description
2.7.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.7.2 Eli Lilly Monoclonal Antibodies Product Introduction
2.7.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.7.2.2 Monoclonal Antibodies Product Information
2.7.3 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Eli Lilly Monoclonal Antibodies Market Share in 2017
2.8 Formation Biologics
2.8.1 Business Overview
2.8.1.1 Formation Biologics Description
2.8.1.2 Formation Biologics Headquarter, Main Business and Finance Overview
2.8.2 Formation Biologics Monoclonal Antibodies Product Introduction
2.8.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.8.2.2 Monoclonal Antibodies Product Information
2.8.3 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Formation Biologics Monoclonal Antibodies Market Share in 2017
2.9 Genmab
2.9.1 Business Overview
2.9.1.1 Genmab Description
2.9.1.2 Genmab Headquarter, Main Business and Finance Overview
2.9.2 Genmab Monoclonal Antibodies Product Introduction
2.9.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.9.2.2 Monoclonal Antibodies Product Information
2.9.3 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Genmab Monoclonal Antibodies Market Share in 2017
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.1.1 GlaxoSmithKline Description
2.10.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.10.2 GlaxoSmithKline Monoclonal Antibodies Product Introduction
2.10.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.10.2.2 Monoclonal Antibodies Product Information
2.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global GlaxoSmithKline Monoclonal Antibodies Market Share in 2017
2.11 Human Genome Sciences
2.11.1 Business Overview
2.11.2 Human Genome Sciences Monoclonal Antibodies Product Introduction
2.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 mmunogen
2.12.1 Business Overview
2.12.2 mmunogen Monoclonal Antibodies Product Introduction
2.12.3 mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MedImmune
2.13.1 Business Overview
2.13.2 MedImmune Monoclonal Antibodies Product Introduction
2.13.3 MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novartis
2.14.1 Business Overview
2.14.2 Novartis Monoclonal Antibodies Product Introduction
2.14.3 Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Pfizer Monoclonal Antibodies Product Introduction
2.15.3 Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Seattle Genetics
2.16.1 Business Overview
2.16.2 Seattle Genetics Monoclonal Antibodies Product Introduction
2.16.3 Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Stemcentrx
2.17.1 Business Overview
2.17.2 Stemcentrx Monoclonal Antibodies Product Introduction
2.17.3 Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthon Biopharmaceuticals
2.18.1 Business Overview
2.18.2 Synthon Biopharmaceuticals Monoclonal Antibodies Product Introduction
2.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Takeda
2.19.1 Business Overview
2.19.2 Takeda Monoclonal Antibodies Product Introduction
2.19.3 Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Teva
2.20.1 Business Overview
2.20.2 Teva Monoclonal Antibodies Product Introduction
2.20.3 Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL MONOCLONAL ANTIBODIES MARKET COMPETITION, BY MANUFACTURER
3.1 Global Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Monoclonal Antibodies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2017
3.4.2 Top 5 Monoclonal Antibodies Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY REGIONS
4.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Monoclonal Antibodies Sales by Regions (2013-2018)
4.1.2 Global Monoclonal Antibodies Revenue by Regions (2013-2018)
4.2 North America Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Monoclonal Antibodies Sales by Countries (2013-2018)
5.1.2 North America Monoclonal Antibodies Revenue by Countries (2013-2018)
5.1.3 United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.4 Canada Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.5 Mexico Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.2 North America Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Monoclonal Antibodies Sales by Manufacturers (2016-2017)
5.2.2 North America Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
5.3 North America Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
5.3.2 North America Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
5.4.2 North America Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Monoclonal Antibodies Sales by Countries (2013-2018)
6.1.2 Europe Monoclonal Antibodies Revenue by Countries (2013-2018)
6.1.3 Germany Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.4 UK Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.5 France Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.6 Russia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.7 Italy Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.2 Europe Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Monoclonal Antibodies Sales by Manufacturers (2016-2017)
6.2.2 Europe Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
6.3 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Monoclonal Antibodies Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Monoclonal Antibodies Revenue by Countries (2013-2018)
7.1.3 China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.4 Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.5 Korea Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.6 India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Monoclonal Antibodies Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Monoclonal Antibodies Sales by Countries (2013-2018)
8.1.2 South America Monoclonal Antibodies Revenue by Countries (2013-2018)
8.1.3 Brazil Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.4 Argentina Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.5 Colombia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.2 South America Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Monoclonal Antibodies Sales by Manufacturers (2016-2017)
8.2.2 South America Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
8.3 South America Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
8.3.2 South America Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
8.4.2 South America Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Monoclonal Antibodies Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.4 UAE Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.5 Egypt Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.7 South Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Monoclonal Antibodies Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MONOCLONAL ANTIBODIES MARKET SEGMENT BY TYPE
10.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Cancer Sales Growth and Price
10.2.1 Global Cancer Sales Growth (2013-2018)
10.2.2 Global Cancer Price (2013-2018)
10.3 Autoimmune Diseases Sales Growth and Price
10.3.1 Global Autoimmune Diseases Sales Growth (2013-2018)
10.3.2 Global Autoimmune Diseases Price (2013-2018)
10.4 Infection Sales Growth and Price
10.4.1 Global Infection Sales Growth (2013-2018)
10.4.2 Global Infection Price (2013-2018)
10.5 Hematological Diseases Sales Growth and Price
10.5.1 Global Hematological Diseases Sales Growth (2013-2018)
10.5.2 Global Hematological Diseases Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 GLOBAL MONOCLONAL ANTIBODIES MARKET SEGMENT BY APPLICATION
11.1 Global Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Autoimmune and inflammatory diseases Sales Growth (2013-2018)
11.4 Respiratory diseases Sales Growth (2013-2018)
11.5 Ophthalmology Sales Growth (2013-2018)
12 MONOCLONAL ANTIBODIES MARKET FORECAST (2018-2023)
12.1 Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.2 Europe Monoclonal Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Monoclonal Antibodies Market Forecast (2018-2023)
12.2.4 South America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Monoclonal Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Monoclonal Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Monoclonal Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Cancer
1.2.2 Autoimmune Diseases
1.2.3 Infection
1.2.4 Hematological Diseases
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Autoimmune and inflammatory diseases
1.3.3 Respiratory diseases
1.3.4 Ophthalmology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.1.1 AbbVie Description
2.1.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.1.2 AbbVie Monoclonal Antibodies Product Introduction
2.1.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.1.2.2 Monoclonal Antibodies Product Information
2.1.3 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global AbbVie Monoclonal Antibodies Market Share in 2017
2.2 Roche
2.2.1 Business Overview
2.2.1.1 Roche Description
2.2.1.2 Roche Headquarter, Main Business and Finance Overview
2.2.2 Roche Monoclonal Antibodies Product Introduction
2.2.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.2.2.2 Monoclonal Antibodies Product Information
2.2.3 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Roche Monoclonal Antibodies Market Share in 2017
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.1.1 Johnson & Johnson Description
2.3.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.3.2 Johnson & Johnson Monoclonal Antibodies Product Introduction
2.3.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.3.2.2 Monoclonal Antibodies Product Information
2.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Johnson & Johnson Monoclonal Antibodies Market Share in 2017
2.4 Amgen
2.4.1 Business Overview
2.4.1.1 Amgen Description
2.4.1.2 Amgen Headquarter, Main Business and Finance Overview
2.4.2 Amgen Monoclonal Antibodies Product Introduction
2.4.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.4.2.2 Monoclonal Antibodies Product Information
2.4.3 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Amgen Monoclonal Antibodies Market Share in 2017
2.5 Merck
2.5.1 Business Overview
2.5.1.1 Merck Description
2.5.1.2 Merck Headquarter, Main Business and Finance Overview
2.5.2 Merck Monoclonal Antibodies Product Introduction
2.5.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.5.2.2 Monoclonal Antibodies Product Information
2.5.3 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Merck Monoclonal Antibodies Market Share in 2017
2.6 BMS
2.6.1 Business Overview
2.6.1.1 BMS Description
2.6.1.2 BMS Headquarter, Main Business and Finance Overview
2.6.2 BMS Monoclonal Antibodies Product Introduction
2.6.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.6.2.2 Monoclonal Antibodies Product Information
2.6.3 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global BMS Monoclonal Antibodies Market Share in 2017
2.7 Eli Lilly
2.7.1 Business Overview
2.7.1.1 Eli Lilly Description
2.7.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.7.2 Eli Lilly Monoclonal Antibodies Product Introduction
2.7.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.7.2.2 Monoclonal Antibodies Product Information
2.7.3 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Eli Lilly Monoclonal Antibodies Market Share in 2017
2.8 Formation Biologics
2.8.1 Business Overview
2.8.1.1 Formation Biologics Description
2.8.1.2 Formation Biologics Headquarter, Main Business and Finance Overview
2.8.2 Formation Biologics Monoclonal Antibodies Product Introduction
2.8.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.8.2.2 Monoclonal Antibodies Product Information
2.8.3 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Formation Biologics Monoclonal Antibodies Market Share in 2017
2.9 Genmab
2.9.1 Business Overview
2.9.1.1 Genmab Description
2.9.1.2 Genmab Headquarter, Main Business and Finance Overview
2.9.2 Genmab Monoclonal Antibodies Product Introduction
2.9.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.9.2.2 Monoclonal Antibodies Product Information
2.9.3 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Genmab Monoclonal Antibodies Market Share in 2017
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.1.1 GlaxoSmithKline Description
2.10.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.10.2 GlaxoSmithKline Monoclonal Antibodies Product Introduction
2.10.2.1 Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.10.2.2 Monoclonal Antibodies Product Information
2.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global GlaxoSmithKline Monoclonal Antibodies Market Share in 2017
2.11 Human Genome Sciences
2.11.1 Business Overview
2.11.2 Human Genome Sciences Monoclonal Antibodies Product Introduction
2.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 mmunogen
2.12.1 Business Overview
2.12.2 mmunogen Monoclonal Antibodies Product Introduction
2.12.3 mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MedImmune
2.13.1 Business Overview
2.13.2 MedImmune Monoclonal Antibodies Product Introduction
2.13.3 MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novartis
2.14.1 Business Overview
2.14.2 Novartis Monoclonal Antibodies Product Introduction
2.14.3 Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Pfizer Monoclonal Antibodies Product Introduction
2.15.3 Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Seattle Genetics
2.16.1 Business Overview
2.16.2 Seattle Genetics Monoclonal Antibodies Product Introduction
2.16.3 Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Stemcentrx
2.17.1 Business Overview
2.17.2 Stemcentrx Monoclonal Antibodies Product Introduction
2.17.3 Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthon Biopharmaceuticals
2.18.1 Business Overview
2.18.2 Synthon Biopharmaceuticals Monoclonal Antibodies Product Introduction
2.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Takeda
2.19.1 Business Overview
2.19.2 Takeda Monoclonal Antibodies Product Introduction
2.19.3 Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Teva
2.20.1 Business Overview
2.20.2 Teva Monoclonal Antibodies Product Introduction
2.20.3 Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL MONOCLONAL ANTIBODIES MARKET COMPETITION, BY MANUFACTURER
3.1 Global Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Monoclonal Antibodies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2017
3.4.2 Top 5 Monoclonal Antibodies Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY REGIONS
4.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Monoclonal Antibodies Sales by Regions (2013-2018)
4.1.2 Global Monoclonal Antibodies Revenue by Regions (2013-2018)
4.2 North America Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Monoclonal Antibodies Sales by Countries (2013-2018)
5.1.2 North America Monoclonal Antibodies Revenue by Countries (2013-2018)
5.1.3 United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.4 Canada Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.5 Mexico Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.2 North America Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Monoclonal Antibodies Sales by Manufacturers (2016-2017)
5.2.2 North America Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
5.3 North America Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
5.3.2 North America Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
5.4.2 North America Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Monoclonal Antibodies Sales by Countries (2013-2018)
6.1.2 Europe Monoclonal Antibodies Revenue by Countries (2013-2018)
6.1.3 Germany Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.4 UK Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.5 France Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.6 Russia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.7 Italy Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.2 Europe Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Monoclonal Antibodies Sales by Manufacturers (2016-2017)
6.2.2 Europe Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
6.3 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Monoclonal Antibodies Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Monoclonal Antibodies Revenue by Countries (2013-2018)
7.1.3 China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.4 Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.5 Korea Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.6 India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Monoclonal Antibodies Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Monoclonal Antibodies Sales by Countries (2013-2018)
8.1.2 South America Monoclonal Antibodies Revenue by Countries (2013-2018)
8.1.3 Brazil Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.4 Argentina Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.5 Colombia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.2 South America Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Monoclonal Antibodies Sales by Manufacturers (2016-2017)
8.2.2 South America Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
8.3 South America Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
8.3.2 South America Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
8.4.2 South America Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Monoclonal Antibodies Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.4 UAE Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.5 Egypt Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.7 South Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Monoclonal Antibodies Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MONOCLONAL ANTIBODIES MARKET SEGMENT BY TYPE
10.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Cancer Sales Growth and Price
10.2.1 Global Cancer Sales Growth (2013-2018)
10.2.2 Global Cancer Price (2013-2018)
10.3 Autoimmune Diseases Sales Growth and Price
10.3.1 Global Autoimmune Diseases Sales Growth (2013-2018)
10.3.2 Global Autoimmune Diseases Price (2013-2018)
10.4 Infection Sales Growth and Price
10.4.1 Global Infection Sales Growth (2013-2018)
10.4.2 Global Infection Price (2013-2018)
10.5 Hematological Diseases Sales Growth and Price
10.5.1 Global Hematological Diseases Sales Growth (2013-2018)
10.5.2 Global Hematological Diseases Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 GLOBAL MONOCLONAL ANTIBODIES MARKET SEGMENT BY APPLICATION
11.1 Global Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Autoimmune and inflammatory diseases Sales Growth (2013-2018)
11.4 Respiratory diseases Sales Growth (2013-2018)
11.5 Ophthalmology Sales Growth (2013-2018)
12 MONOCLONAL ANTIBODIES MARKET FORECAST (2018-2023)
12.1 Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.2 Europe Monoclonal Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Monoclonal Antibodies Market Forecast (2018-2023)
12.2.4 South America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Monoclonal Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Monoclonal Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Monoclonal Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data
LIST OF TABLES AND FIGURES
Figure Monoclonal Antibodies Picture
Table Product Specifications of Monoclonal Antibodies
Figure Global Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Monoclonal Antibodies by Types in 2017
Figure Cancer Picture
Table Major Manufacturers of Cancer
Figure Autoimmune Diseases Picture
Table Major Manufacturers of Autoimmune Diseases
Figure Infection Picture
Table Major Manufacturers of Infection
Figure Hematological Diseases Picture
Table Major Manufacturers of Hematological Diseases
Figure Others Picture
Table Major Manufacturers of Others
Figure Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Autoimmune and inflammatory diseases Picture
Figure Respiratory diseases Picture
Figure Ophthalmology Picture
Figure United States Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table AbbVie Monoclonal Antibodies Product
Table AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Monoclonal Antibodies Sales Market Share in 2017
Figure Global AbbVie Monoclonal Antibodies Revenue Market Share in 2017
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Roche Monoclonal Antibodies Product
Table Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Monoclonal Antibodies Sales Market Share in 2017
Figure Global Roche Monoclonal Antibodies Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Monoclonal Antibodies Product
Table Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Monoclonal Antibodies Sales Market Share in 2017
Figure Global Johnson & Johnson Monoclonal Antibodies Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Amgen Monoclonal Antibodies Product
Table Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Monoclonal Antibodies Sales Market Share in 2017
Figure Global Amgen Monoclonal Antibodies Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Merck Monoclonal Antibodies Product
Table Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Monoclonal Antibodies Sales Market Share in 2017
Figure Global Merck Monoclonal Antibodies Revenue Market Share in 2017
Table BMS Headquarter, Established, Main Business and Finance Overview (2017)
Table BMS Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table BMS Monoclonal Antibodies Product
Table BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BMS Monoclonal Antibodies Sales Market Share in 2017
Figure Global BMS Monoclonal Antibodies Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Monoclonal Antibodies Product
Table Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Monoclonal Antibodies Sales Market Share in 2017
Figure Global Eli Lilly Monoclonal Antibodies Revenue Market Share in 2017
Table Formation Biologics Headquarter, Established, Main Business and Finance Overview (2017)
Table Formation Biologics Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Formation Biologics Monoclonal Antibodies Product
Table Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Formation Biologics Monoclonal Antibodies Sales Market Share in 2017
Figure Global Formation Biologics Monoclonal Antibodies Revenue Market Share in 2017
Table Genmab Headquarter, Established, Main Business and Finance Overview (2017)
Table Genmab Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Genmab Monoclonal Antibodies Product
Table Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genmab Monoclonal Antibodies Sales Market Share in 2017
Figure Global Genmab Monoclonal Antibodies Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Monoclonal Antibodies Product
Table GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Monoclonal Antibodies Sales Market Share in 2017
Figure Global GlaxoSmithKline Monoclonal Antibodies Revenue Market Share in 2017
Table Human Genome Sciences
Table Human Genome Sciences Monoclonal Antibodies
Table mmunogen
Table mmunogen Monoclonal Antibodies
Table MedImmune
Table MedImmune Monoclonal Antibodies
Table Novartis
Table Novartis Monoclonal Antibodies
Table Pfizer
Table Pfizer Monoclonal Antibodies
Table Seattle Genetics
Table Seattle Genetics Monoclonal Antibodies
Table Stemcentrx
Table Stemcentrx Monoclonal Antibodies
Table Synthon Biopharmaceuticals
Table Synthon Biopharmaceuticals Monoclonal Antibodies
Table Takeda
Table Takeda Monoclonal Antibodies
Table Teva
Table Teva Monoclonal Antibodies
Table Global Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Global Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Global Monoclonal Antibodies Price by Manufacturer (2016-2017)
Figure Top 3 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Global Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Global Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Global Monoclonal Antibodies Sales by Regions (2013-2018)
Table Global Monoclonal Antibodies Sales Market Share by Regions (2013-2018)
Table Global Monoclonal Antibodies Revenue by Regions (2013-2018)
Figure Global Monoclonal Antibodies Revenue Market Share by Regions in 2013
Figure Global Monoclonal Antibodies Revenue Market Share by Regions in 2017
Figure North America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure North America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Europe Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure South America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure North America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table North America Monoclonal Antibodies Sales by Countries (2013-2018)
Table North America Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure North America Monoclonal Antibodies Sales Market Share by Countries in 2013
Figure North America Monoclonal Antibodies Sales Market Share by Countries in 2017
Table North America Monoclonal Antibodies Revenue by Countries (2013-2018)
Table North America Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure North America Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Canada Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Mexico Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table North America Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure North America Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure North America Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table North America Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure North America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure North America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table North America Monoclonal Antibodies Sales by Type (2013-2018)
Table North America Monoclonal Antibodies Sales Share by Type (2013-2018)
Table North America Monoclonal Antibodies Revenue by Type (2013-2018)
Table North America Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table North America Monoclonal Antibodies Sales by Application (2013-2018)
Table North America Monoclonal Antibodies Sales Share by Application (2013-2018)
Table North America Monoclonal Antibodies Revenue by Application (2013-2018)
Table North America Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Europe Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Monoclonal Antibodies Sales by Countries (2013-2018)
Table Europe Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Europe Monoclonal Antibodies Revenue Market Share by Countries in 2016
Figure Europe Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Germany Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UK Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure France Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Russia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Italy Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Europe Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Europe Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Europe Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Europe Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Europe Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Europe Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Europe Monoclonal Antibodies Sales by Type (2013-2018)
Table Europe Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Type (2013-2018)
Table Europe Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Europe Monoclonal Antibodies Sales by Application (2013-2018)
Table Europe Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Application (2013-2018)
Table Europe Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Countries (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Countries 2017
Table Asia-Pacific Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Countries 2017
Figure China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Korea Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Monoclonal Antibodies Sales by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure South America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table South America Monoclonal Antibodies Sales by Countries (2013-2018)
Table South America Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure South America Monoclonal Antibodies Sales Market Share by Countries in 2017
Table South America Monoclonal Antibodies Revenue by Countries (2013-2018)
Table South America Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Argentina Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Colombia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table South America Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure South America Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure South America Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table South America Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure South America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure South America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table South America Monoclonal Antibodies Sales by Type (2013-2018)
Table South America Monoclonal Antibodies Sales Share by Type (2013-2018)
Table South America Monoclonal Antibodies Revenue by Type (2013-2018)
Table South America Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table South America Monoclonal Antibodies Sales by Application (2013-2018)
Table South America Monoclonal Antibodies Sales Share by Application (2013-2018)
Table South America Monoclonal Antibodies Revenue by Application (2013-2018)
Table South America Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Countries (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries in 2017
Table Middle East and Africa Monoclonal Antibodies Revenue by Countries (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UAE Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Egypt Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Nigeria Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Monoclonal Antibodies Sales by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Share by Application (2013-2018)
Table Global Monoclonal Antibodies Sales by Type (2013-2018)
Table Global Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Global Monoclonal Antibodies Revenue by Type (2013-2018)
Table Global Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Cancer Price (2013-2018)
Figure Global Autoimmune Diseases Sales Growth (2013-2018)
Figure Global Autoimmune Diseases Price (2013-2018)
Figure Global Infection Sales Growth (2013-2018)
Figure Global Infection Price (2013-2018)
Figure Global Hematological Diseases Sales Growth (2013-2018)
Figure Global Hematological Diseases Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Monoclonal Antibodies Sales by Application (2013-2018)
Table Global Monoclonal Antibodies Sales Share by Application (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Autoimmune and inflammatory diseases Sales Growth (2013-2018)
Figure Global Respiratory diseases Sales Growth (2013-2018)
Figure Global Ophthalmology Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Regions (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Regions (2018-2023)
Figure North America Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Europe Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Asia-Pacific Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure South America Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Middle East and Africa Sales Monoclonal Antibodies Market Forecast (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Type (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Application (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Monoclonal Antibodies Picture
Table Product Specifications of Monoclonal Antibodies
Figure Global Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Monoclonal Antibodies by Types in 2017
Figure Cancer Picture
Table Major Manufacturers of Cancer
Figure Autoimmune Diseases Picture
Table Major Manufacturers of Autoimmune Diseases
Figure Infection Picture
Table Major Manufacturers of Infection
Figure Hematological Diseases Picture
Table Major Manufacturers of Hematological Diseases
Figure Others Picture
Table Major Manufacturers of Others
Figure Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Autoimmune and inflammatory diseases Picture
Figure Respiratory diseases Picture
Figure Ophthalmology Picture
Figure United States Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table AbbVie Monoclonal Antibodies Product
Table AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Monoclonal Antibodies Sales Market Share in 2017
Figure Global AbbVie Monoclonal Antibodies Revenue Market Share in 2017
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Roche Monoclonal Antibodies Product
Table Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Monoclonal Antibodies Sales Market Share in 2017
Figure Global Roche Monoclonal Antibodies Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Monoclonal Antibodies Product
Table Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Monoclonal Antibodies Sales Market Share in 2017
Figure Global Johnson & Johnson Monoclonal Antibodies Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Amgen Monoclonal Antibodies Product
Table Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Monoclonal Antibodies Sales Market Share in 2017
Figure Global Amgen Monoclonal Antibodies Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Merck Monoclonal Antibodies Product
Table Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Monoclonal Antibodies Sales Market Share in 2017
Figure Global Merck Monoclonal Antibodies Revenue Market Share in 2017
Table BMS Headquarter, Established, Main Business and Finance Overview (2017)
Table BMS Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table BMS Monoclonal Antibodies Product
Table BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BMS Monoclonal Antibodies Sales Market Share in 2017
Figure Global BMS Monoclonal Antibodies Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Monoclonal Antibodies Product
Table Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Monoclonal Antibodies Sales Market Share in 2017
Figure Global Eli Lilly Monoclonal Antibodies Revenue Market Share in 2017
Table Formation Biologics Headquarter, Established, Main Business and Finance Overview (2017)
Table Formation Biologics Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Formation Biologics Monoclonal Antibodies Product
Table Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Formation Biologics Monoclonal Antibodies Sales Market Share in 2017
Figure Global Formation Biologics Monoclonal Antibodies Revenue Market Share in 2017
Table Genmab Headquarter, Established, Main Business and Finance Overview (2017)
Table Genmab Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Genmab Monoclonal Antibodies Product
Table Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genmab Monoclonal Antibodies Sales Market Share in 2017
Figure Global Genmab Monoclonal Antibodies Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Monoclonal Antibodies Product
Table GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Monoclonal Antibodies Sales Market Share in 2017
Figure Global GlaxoSmithKline Monoclonal Antibodies Revenue Market Share in 2017
Table Human Genome Sciences
Table Human Genome Sciences Monoclonal Antibodies
Table mmunogen
Table mmunogen Monoclonal Antibodies
Table MedImmune
Table MedImmune Monoclonal Antibodies
Table Novartis
Table Novartis Monoclonal Antibodies
Table Pfizer
Table Pfizer Monoclonal Antibodies
Table Seattle Genetics
Table Seattle Genetics Monoclonal Antibodies
Table Stemcentrx
Table Stemcentrx Monoclonal Antibodies
Table Synthon Biopharmaceuticals
Table Synthon Biopharmaceuticals Monoclonal Antibodies
Table Takeda
Table Takeda Monoclonal Antibodies
Table Teva
Table Teva Monoclonal Antibodies
Table Global Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Global Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Global Monoclonal Antibodies Price by Manufacturer (2016-2017)
Figure Top 3 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Global Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Global Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Global Monoclonal Antibodies Sales by Regions (2013-2018)
Table Global Monoclonal Antibodies Sales Market Share by Regions (2013-2018)
Table Global Monoclonal Antibodies Revenue by Regions (2013-2018)
Figure Global Monoclonal Antibodies Revenue Market Share by Regions in 2013
Figure Global Monoclonal Antibodies Revenue Market Share by Regions in 2017
Figure North America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure North America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Europe Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure South America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure North America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table North America Monoclonal Antibodies Sales by Countries (2013-2018)
Table North America Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure North America Monoclonal Antibodies Sales Market Share by Countries in 2013
Figure North America Monoclonal Antibodies Sales Market Share by Countries in 2017
Table North America Monoclonal Antibodies Revenue by Countries (2013-2018)
Table North America Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure North America Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Canada Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Mexico Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table North America Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure North America Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure North America Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table North America Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure North America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure North America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table North America Monoclonal Antibodies Sales by Type (2013-2018)
Table North America Monoclonal Antibodies Sales Share by Type (2013-2018)
Table North America Monoclonal Antibodies Revenue by Type (2013-2018)
Table North America Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table North America Monoclonal Antibodies Sales by Application (2013-2018)
Table North America Monoclonal Antibodies Sales Share by Application (2013-2018)
Table North America Monoclonal Antibodies Revenue by Application (2013-2018)
Table North America Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Europe Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Monoclonal Antibodies Sales by Countries (2013-2018)
Table Europe Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Europe Monoclonal Antibodies Revenue Market Share by Countries in 2016
Figure Europe Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Germany Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UK Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure France Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Russia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Italy Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Europe Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Europe Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Europe Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Europe Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Europe Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Europe Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Europe Monoclonal Antibodies Sales by Type (2013-2018)
Table Europe Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Type (2013-2018)
Table Europe Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Europe Monoclonal Antibodies Sales by Application (2013-2018)
Table Europe Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Europe Monoclonal Antibodies Revenue by Application (2013-2018)
Table Europe Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Countries (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Countries 2017
Table Asia-Pacific Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Countries 2017
Figure China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Korea Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Monoclonal Antibodies Sales by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue by Application (2013-2018)
Table Asia-Pacific Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure South America Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table South America Monoclonal Antibodies Sales by Countries (2013-2018)
Table South America Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure South America Monoclonal Antibodies Sales Market Share by Countries in 2017
Table South America Monoclonal Antibodies Revenue by Countries (2013-2018)
Table South America Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Argentina Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Colombia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table South America Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure South America Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure South America Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table South America Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure South America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure South America Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table South America Monoclonal Antibodies Sales by Type (2013-2018)
Table South America Monoclonal Antibodies Sales Share by Type (2013-2018)
Table South America Monoclonal Antibodies Revenue by Type (2013-2018)
Table South America Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table South America Monoclonal Antibodies Sales by Application (2013-2018)
Table South America Monoclonal Antibodies Sales Share by Application (2013-2018)
Table South America Monoclonal Antibodies Revenue by Application (2013-2018)
Table South America Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Countries (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries in 2017
Table Middle East and Africa Monoclonal Antibodies Revenue by Countries (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UAE Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Egypt Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Nigeria Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Monoclonal Antibodies Sales by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue by Application (2013-2018)
Table Middle East and Africa Monoclonal Antibodies Revenue Share by Application (2013-2018)
Table Global Monoclonal Antibodies Sales by Type (2013-2018)
Table Global Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Global Monoclonal Antibodies Revenue by Type (2013-2018)
Table Global Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Cancer Price (2013-2018)
Figure Global Autoimmune Diseases Sales Growth (2013-2018)
Figure Global Autoimmune Diseases Price (2013-2018)
Figure Global Infection Sales Growth (2013-2018)
Figure Global Infection Price (2013-2018)
Figure Global Hematological Diseases Sales Growth (2013-2018)
Figure Global Hematological Diseases Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Monoclonal Antibodies Sales by Application (2013-2018)
Table Global Monoclonal Antibodies Sales Share by Application (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Autoimmune and inflammatory diseases Sales Growth (2013-2018)
Figure Global Respiratory diseases Sales Growth (2013-2018)
Figure Global Ophthalmology Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Regions (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Regions (2018-2023)
Figure North America Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Europe Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Asia-Pacific Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure South America Sales Monoclonal Antibodies Market Forecast (2018-2023)
Figure Middle East and Africa Sales Monoclonal Antibodies Market Forecast (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Type (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
Table Global Monoclonal Antibodies Sales Forecast by Application (2018-2023)
Table Global Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
